• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Janssen US Medical Affairs - Merging??













This doesn’t make sense strategically. The only thing preventing medical affairs and commercial from working more closely than they do is this big old thing called regulatory and compliance. Why would an organization voluntarily separate the two